FDA approves test to help screen for risk of opioid use disorder
The U.S. FDA approved a novel tool that uses genetic testing to help assess whether certain people are at risk of developing opioid use disorder.
Stay updated with breaking news from Katherine Keyes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The U.S. FDA approved a novel tool that uses genetic testing to help assess whether certain people are at risk of developing opioid use disorder.
The U.S. FDA approved a novel tool that uses genetic testing to help assess whether certain people are at risk of developing opioid use disorder.
The U.S. FDA approved a novel tool that uses genetic testing to help assess whether certain people are at risk of developing opioid use disorder.
The U.S. FDA approved a novel tool that uses genetic testing to help assess whether certain people are at risk of developing opioid use disorder.
The U.S. FDA approved a novel tool that uses genetic testing to help assess whether certain people are at risk of developing opioid use disorder.